MuscleTech SX-7 Black Onyx #Shatter
Natural health product licensed in Canada
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80069560
- Status
- Active licence
- Licence date
- 19 May 2016
- Revision date
- 3 April 2017
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Myristica fragrans Houtt.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine Source : Acide nicotinique | 30 mg | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 200 mg | Not calculated |
| Acide 3-aminopropanoïque Source : Beta-alanine | 1,600 mg | Not calculated |
| Adénosine 5'-(disodium triphosphate) Source : Adénosine triphosphate disodium | 200 mg | Not calculated |
| Myristica fragrans Source : Myristica fragrans - Graine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 500 milligramme | 100 mg | Not calculated |
| Sambucus nigra subsp. nigra Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 470 mg | 47 mg | Not calculated |
| Scutellaria lateriflora Source : Sommité | 37.5 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 30 mg | Not calculated |
| Citrus unshiu Source : Fruit | 2 mg | Not calculated |
Non-medicinal ingredients
Rouge FD&C N° 40, Acide DL-malique, Sucralose, Acide citrique, Saveur, Dextrine, Dioxyde de silicium, Maltodextrine, Silicate de calcium, Bleu FD&C n° 1, Acésulfame potassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Mesures | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps (temporarily) to promote alertness and wakefulness and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance and to enhance motor performance. Helps to increase lean mass when used in conjunction with a resistance training regimen and a healthy balance diet. Helps to improve strength and performance in repetitive bouts of brief, highly intense physical activity when combined with a healthy balanced diet. Helps to delay muscle fatigue by increasing carnosine levels. Workout Supplement. Athletic Support. Helps the body to metabolize carbohydrates, fats, and proteins. Help with normal growth, development, and a factor in the maintenance of good health. Helps in the development and maintenance of bones, teeth, gums, and cartilage. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ensure to drink enough fluid before, during, and after exercise. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended.This product is not intended as a substitute for sleep. Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consumption with alcohol, other drugs and/or natural health products with sedative properties is not recommended. Consult a health care practitioner prior to use if you have liver or kidney disease or if you have been instructed to follow a low protein diet. Diuretic effect may occur. If you are taking anti-depressant, especially monoamine oxidase inhibitors consult a health care practitioner prior to use. If you suffer from heartburn or acid reflux, consult a health care practitioner prior to use.
- Effets indésirables connus
May cause a flushing, tingling and/or prickling sensation of the skin, in which case, reduce the dose. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, and irregular heartbeat even in healthy individuals. If those symptoms occur discontinue use and consult a health care practitioner (Higgins 2013). Hypersensitivity (e.g. allergy) can occur, in which case, discontinue use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. Discontinue use in case of gastrointestinal upsets, such as abdominal cramps, nausea, vomiting, diarrhea.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80069560
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sambucus nigra subsp. nigra
Read the warning, when it applies and the studies cited
ELDER – SAMBUCUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Scutellaria lateriflora
Read the warning, when it applies and the studies cited
SKULLCAP - SCUTELLARIA LATERIFLORA
Route of administration: Oral
Cautions and warnings
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Bradley 2006; Tilgner 1999; Williamson et al. 1988; Ellingwood 1983; Felter and Lloyd 1983).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Barnes et al. 2007; Boon and Smith 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.